Skip to main content

Published locations for Brodalumab suicide risk similar to other biologics, postmarket study finds

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Brodalumab suicide risk similar to other biologics, postmarket study finds

User login

  • Reset your password
  • /content/brodalumab-suicide-risk-similar-other-biologics-postmarket-study-finds
  • /edermatologynews/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /familypracticenews/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics
  • /fedprac/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket-study
  • /internalmedicinenews/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics
  • /rheumatologynews/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /psychiatry/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket-study
  • /rheumatology/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /internalmedicine/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /dermatology/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /familymedicine/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics-postmarket
  • /psoriatic-arthritis-icymi/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics
  • /clinicalpsychiatrynews/article/258020/psoriasis/brodalumab-suicide-risk-similar-other-biologics